•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.BioVaxys Presents Further Validation of the Robust Immune Response from a Combination of MVP-S with Checkpoint Inhibitors and Low-Dose Cyclophosphamide in Ovarian Cancer
First Horizon Recognized with a 2026 Training MVP Award by Training Magazine
BioVaxys Reports Positive Phase 2 Data for Maveropepimut (MVP-S) + Pembrolizumab and Low-Dose Cyclophosphamide in Metastatic Bladder Cancer
BioVaxys Reports Positive Clinical Study Results from Phase 1B/2 PESCO Trial of MVP-S with Pembrolizumab (Keytruda (TM)) and Low-Dose Cyclophosphamide for Patients with Recurrent Epithelial Ovarian Cancer (EOC)
Digitalage Announces MVP Launch for Live, Creator-First Media Platform
BioVaxys Announces Positive Phase 1 Clinical Study Results with Maveropepimut-S (MVP-S) in Women with Hormone Receptor Positive/HER2 Negative (HR+/HER2-) Stage II-III Breast Cancer
Firestone Partners, Matterhorn Venture Partners, and Fox Capital Partners Form Joint Venture for Atlanta Industrial Acquisition
Mountain Valley Pipeline, LLC Files Formal Application Requesting FERC Authorization to Construct MVP Boost
NFL MVP Josh Allen leaves Nike to sign with New Balance
Wheaties Unveils Football MVP Jalen Hurts as the Newest Champion of the Iconic Orange Box
MVP Health Care and Renalytix Partner to Bring Life-Changing Kidney Disease Testing to Local Communities
NBA® 2K26 Unveils 2025 MVP and Finals MVP Shai Gilgeous-Alexander, WNBA All-Star Angel Reese, and Hall of Famer Carmelo Anthony as Cover Athletes
FlexCare: The New MVP in Stellantis Vehicle Service
USANA Athlete Natalie Spooner Wins Inaugural PWHL MVP Award
2 Energy Stocks Likely to Benefit From MVP's Operational Launch
Mealthy Welcomes Original Shark Tank Investor Kevin Harrington as an Advisor
MVP Holdings Inc. Receives Current Status on OTC Markets
NATIONAL LEAGUE